EirGenix Inc. announced the establishment of the company's Corporate Governance Committee with Lee-Cheng Liu: President & CEO, EirGenix, Inc; Ming-Thaur Chang: Independent Director, DBS Bank (Taiwan) Ltd.; Fu-Shiow Yin: Independent Director, Foresee Pharmaceuticals Co. Ltd.; Ming-Shen Chen: Professor of Finance at National Taiwan University.; and Po-Chih Chen: Senior Advisors to the President, effective December 28, 2022. Mr. Ming-Shen Chen is the chairman of first term Corporate Governance Committee.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
78.5 TWD | +0.26% | -2.24% | -21.89% |
May. 15 | EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 22 | EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.89% | 741M | |
+0.82% | 93.19B | |
-1.32% | 39.62B | |
-12.88% | 33.78B | |
+64.77% | 26.82B | |
-16.31% | 15.35B | |
-5.78% | 13.13B | |
-11.38% | 11.6B | |
-49.84% | 10.26B | |
+5.24% | 9.43B |
- Stock Market
- Equities
- 6589 Stock
- News EirGenix Inc.
- Eirgenix Inc. Announces Establishment of Corporate Governance Committee